Last reviewed · How we verify
NCT06739616
Expanding Interventions for Automatically Maintained SIB
NA trial testing AUTOSIB across time in Self-Injurious Behavior in 7 participants. Completed in 31 August 2024.
31 August 2024
Quick facts
| Lead sponsor | University of Georgia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 7 |
| Start date | 18 April 2023 |
| Primary completion | 31 August 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- AUTOSIB across time
- AUTOSIB diminished reinforcement
Conditions studied
- Self-Injurious Behavior — all drugs for Self-Injurious Behavior →
- Problem Behavior — all drugs for Problem Behavior →
- Intellectual Disability — all drugs for Intellectual Disability →
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
Sponsor
University of Georgia
Who can join
2 and older, any sex, with Self-Injurious Behavior or Problem Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to demonstrate feasibility of procedures and compare the outcomes of intervention arrangements to reduce sensory based self-injurious behavior exhibited by individuals with intellectual and developmental disabilities. The main question\[s\] it aims to answer are: (1) Demonstrate ability to meet enrollment requirements. (2) Evaluate acceptability and feasibility of participation relative to observation length and study duration. (3) Track and compare participant progress across interventions. (4) Demonstrate acceptable procedural fidelity and interobserver agreement. And (5) conduct post hoc evaluation of clinical presentation and intervention match. Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06739616
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Self-Injurious Behavior
Currently open trials in the same condition.
- NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
- NCT07278544 — Harnessing Communication Preferences · NA · recruiting
- NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
- NCT06919432 — Efficacy of Triple-daily 15mA tACS on Adolescent NSSI · NA · recruiting
- NCT05969080 — Self-Injury Treatment and Recovery in Veterans · NA · recruiting
Other University of Georgia trials
Trials by the same sponsor.
- NCT07173816 — Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and S · NA · not yet recruiting
- NCT06799702 — Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inje · NA · not yet recruiting
- NCT06987526 — Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alco · NA · recruiting
- NCT06193343 — Steps Towards Osteoarthritis Prevention · NA · recruiting
- NCT06424756 — Effects of an Antioxidant Supplement on Blood Vessel Health · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06739616 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Georgia
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06739616.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing